GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV
    3.
    发明申请
    GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV 审中-公开
    糖尿病感染化合物及其抑制方法

    公开(公告)号:US20160289257A1

    公开(公告)日:2016-10-06

    申请号:US15182819

    申请日:2016-06-15

    IPC分类号: C07H15/207 C07H15/26

    摘要: Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.

    摘要翻译: 提供化合物,组合物和方法用于抑制人免疫缺陷病毒(HIV)的感染。 更具体地,本发明涉及抑制HIV感染的糖模拟化合物及其用途。

    E-SELECTIN ANTAGONIST COMPOUNDS AND METHODS OF USE
    6.
    发明申请
    E-SELECTIN ANTAGONIST COMPOUNDS AND METHODS OF USE 审中-公开
    E-选择性拮抗剂化合物及其使用方法

    公开(公告)号:US20150284420A1

    公开(公告)日:2015-10-08

    申请号:US14439462

    申请日:2013-10-31

    IPC分类号: C07H15/24 A61N5/10 C07H15/203

    摘要: Provided herein are E-selectin antagonist therapeutic agents and improvements thereto and compositions comprising these E-selectin antagonists. Methods are also provided for using these E-selectin antagonist therapeutic agents to treat and/or prevent diseases and disorders treatable by inhibiting binding of an E-selectin to an E-selectin ligand. Also provided herein improvements to E-selectin antagonist glycomimetic compounds that improve the oral bioavailability of the glycomimetic compounds.

    摘要翻译: 本文提供了E-选择素拮抗剂治疗剂及其改进,以及包含这些E-选择蛋白拮抗剂的组合物。 还提供了使用这些E-选择蛋白拮抗剂治疗剂治疗和/或预防通过抑制E-选择素与E-选择素配体的结合可治疗的疾病和病症的方法。 本文还提供了改善糖模拟化合物的口服生物利用度的E-选择素拮抗剂糖模拟化合物的改进。

    E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE
    9.
    发明申请
    E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE 有权
    E-选择性拮抗剂化合物,组合物和使用方法

    公开(公告)号:US20150110808A1

    公开(公告)日:2015-04-23

    申请号:US14367561

    申请日:2012-12-21

    摘要: Methods and compositions using E-selectin antagonists are provided for the treatment and prevention of diseases and disorders treatable by inhibiting binding of E-selectin to an E-selectin ligand. Described herein are E-selectin antagonists including, for example, glycomimetic compounds, antibodies, aptamers and peptides that are useful in methods for treatment of cancers, and treatment and prevention of metastasis, inhibiting infiltration of the cancer cells into bone marrow, reducing or inhibiting adhesion of the cancer cells to endothelial cells including cells in bone marrow, and inhibiting thrombus formation.

    摘要翻译: 提供使用E-选择蛋白拮抗剂的方法和组合物用于治疗和预防通过抑制E-选择素与E-选择蛋白配体的结合可治疗的疾病和病症。 本文描述的是E-选择蛋白拮抗剂,包括例如可用于治疗癌症的方法中的糖模拟化合物,抗体,适体和肽,以及治疗和预防转移,抑制癌细胞渗入骨髓,减少或抑制 癌细胞与包括骨髓细胞在内的内皮细胞的粘附,以及抑制血栓形成。